UBR1

ubiquitin protein ligase E3 component n-recognin 1, the group of Ubiquitin protein ligase E3 component n-recognins

Basic information

Region (hg38): 15:42942897-43106113

Links

ENSG00000159459NCBI:197131OMIM:605981HGNC:16808Uniprot:Q8IWV7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Johanson-Blizzard syndrome (Definitive), mode of inheritance: AR
  • Johanson-Blizzard syndrome (Strong), mode of inheritance: AR
  • Johanson-Blizzard syndrome (Supportive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Johanson-Blizzard syndromeARAudiologic/Otolaryngologic; Cardiovascular; Endocrine; Gastrointestinal; HematologicMedical treatment of exocrine pancreatic insufficiency can be beneficial; Awareness of cardiovascular manifestastions (which can include structural malformations as well as cardiomyopathy) can allow early diagnosis and treatment; As the condition can include congenital deafness, early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; Treatment of endocrine manifestations, such as hypothyroidism, growth hormone deficiency, and diabetes mellitus, can be beneficial; Severe anemia requiring transfusions has been described, and awareness may allow prompt diagnosis and treatmentAudiologic/Otolaryngologic; Craniofacial; Dental; Dermatologic; Cardiovascular; Endocrine; Gastrointestinal; Hematologic; Neurologic; Ophthalmologic5171616; 728568; 474625; 4050852; 2645405; 12535044; 12725595; 14647752; 15379429; 16311597; 16632090; 17378628; 18553553; 19058315; 19006206; 19717322; 20556423; 21931868; 20556422; 21429315; 21711208; 22072859; 23463671; 23778732; 24052374

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the UBR1 gene.

  • not_provided (932 variants)
  • Inborn_genetic_diseases (159 variants)
  • Johanson-Blizzard_syndrome (40 variants)
  • UBR1-related_disorder (36 variants)
  • not_specified (20 variants)
  • Microcephaly (2 variants)
  • Intellectual_disability (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the UBR1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000174916.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
361
clinvar
20
clinvar
382
missense
1
clinvar
7
clinvar
205
clinvar
45
clinvar
5
clinvar
263
nonsense
18
clinvar
2
clinvar
20
start loss
0
frameshift
14
clinvar
6
clinvar
20
splice donor/acceptor (+/-2bp)
4
clinvar
17
clinvar
2
clinvar
23
Total 37 32 208 406 25

Highest pathogenic variant AF is 0.00005763367

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
UBR1protein_codingprotein_codingENST00000290650 47163217
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.005490.9951257040441257480.000175
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.407149180.7770.000046311593
Missense in Polyphen146279.140.523033529
Synonymous-0.5463193071.040.00001553135
Loss of Function7.15271070.2530.000005311329

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004780.000478
Ashkenazi Jewish0.00009920.0000992
East Asian0.00005440.0000544
Finnish0.00009250.0000924
European (Non-Finnish)0.0001870.000185
Middle Eastern0.00005440.0000544
South Asian0.0002290.000229
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: E3 ubiquitin-protein ligase which is a component of the N-end rule pathway. Recognizes and binds to proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation. May be involved in pancreatic homeostasis. Binds leucine and is a negative regulator of the leucine-mTOR signaling pathway, thereby controlling cell growth. {ECO:0000269|PubMed:15548684, ECO:0000269|PubMed:16311597, ECO:0000269|PubMed:20298436, ECO:0000269|PubMed:20835242}.;
Disease
DISEASE: Johanson-Blizzard syndrome (JBS) [MIM:243800]: This disorder includes congenital exocrine pancreatic insufficiency, multiple malformations such as nasal wing aplasia, and frequent mental retardation. Pancreas of individuals with JBS do not express UBR1 and show intrauterine-onset destructive pancreatitis. {ECO:0000269|PubMed:16311597, ECO:0000269|PubMed:21931868, ECO:0000269|PubMed:22072859, ECO:0000269|PubMed:24599544, ECO:0000269|PubMed:26149651}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
protein ubiquitylation;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation (Consensus)

Recessive Scores

pRec
0.194

Intolerance Scores

loftool
0.598
rvis_EVS
-0.63
rvis_percentile_EVS
16.81

Haploinsufficiency Scores

pHI
0.655
hipred
N
hipred_score
0.488
ghis
0.607

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.775

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ubr1
Phenotype
growth/size/body region phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); digestive/alimentary phenotype;

Gene ontology

Biological process
protein ubiquitination;negative regulation of TOR signaling;cellular response to leucine;ubiquitin-dependent protein catabolic process via the N-end rule pathway
Cellular component
ubiquitin ligase complex;proteasome complex;cytoplasm;cytosol
Molecular function
protein binding;zinc ion binding;ubiquitin protein ligase activity;leucine binding